FDA-Inspected Site

Dsquared Pharmaceuticals, Inc.

1 FDA inspection is on record for Dsquared Pharmaceuticals, Inc. in Phoenix, United States.

483· Form 483 issued

Phoenix, United States · Last updated July 10, 2026

Overview

  • 1 FDA inspection is on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2018-02-13.

At a glance

Inspections

1

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
6 Feb 2018 – 13 Feb 2018Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

13 Feb 2018
21 CFR 211.142(b)

Storage under appropriate conditions

Cited by Gloria J Baca

13 Feb 2018
21 CFR 211.180(e)(1)

Review of representative number of batches

Cited by Gloria J Baca

13 Feb 2018
21 CFR 211.180(e)(2)

Items to cover on annual reviews

Cited by Gloria J Baca

13 Feb 2018
21 CFR 211.22(a)

Lack of quality control unit

Cited by Gloria J Baca

13 Feb 2018
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Gloria J Baca

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.142(b)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Dsquared Pharmaceuticals, Inc.'s 1 Form 483

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat